MYDECINE

The Buzz Surrounding: Mydecine Innovations Group Inc. (OTC: MYCOF) (CSE: MYCO)

← Back to all news
June 16, 2020

About Mydecine Innovations Group Inc.

Mydecine Innovations Group Inc. is a parent company which operates innovative product divisions in the Naturally Sourced Therapies (NST) space. Mydecine Innovations Group Inc. operates a number of hemp-derived CBD and psilocybin brands that design, manufacture and distribute cutting edge products. Mydecine Innovations Group Inc. further enhances their portfolio with cultivation properties, land assets and retail space.Mindleap Health we are focused on positively impacting society through a disruptive platform for psychedelic aftercare and by developing new forms of medicine.

Technology

Mindleap is a digital health platform that helps people connect with mental health specialists that can empower them to thrive and develop habits for a healthy mind. Online mental healthcare brings convenience, improves access to treatments and can lead to more personal breakthroughs. Mindleap’s proprietary platform is designed by clinical psychologists and neuroscientists to provide professional support and personalized treatment for every person.

The Mindleap platform will provide support for people that are looking to achieve personal transformations and overcome mental health challenges. Mindleap is the only digital health platform that combines telehealth with mood, emotion and habit tracking.

Mydecine Farms aims to be a pioneer in the cultivation and genetic IP development of mushrooms and Fungi. The Company is comprised of scientific and horticulture experts that have years of experience in the isolation of compounds, genetic composition development, large scale horticulture and IP and patent formulation.

Mydecine Labs will be a trailblazer in the research, development and discovery of groundbreaking IP derived from psychedelic compounds, namely psilocybin, found in various strains of mushroom and fungi. The Company intends to have a two prong approach both public and private, leveraging its extensive science team as well as partnerships with pertinent departments of major universities.